Literature DB >> 3025667

Activation of oncogenicity of the c-rel proto-oncogene.

B S Sylla, H M Temin.   

Abstract

Reticuloendotheliosis virus strain T (Rev-T) induces a lethal lymphoma in young birds and transforms avian lymphoid cells in vitro. The transforming gene of Rev-T, v-rel, was derived from the turkey proto-oncogene c-rel. Comparison of the nucleotide sequences of v-rel and c-rel indicates that in addition to several internal amino acid changes relative to c-rel, p59v-rel has amino acid sequences at both ends derived from the reticuloendotheliosis virus strain A-related virus env gene (K. C. Wilhelmsen, K. Eggleton, and H. M. Temin, J. Virol. 52:172-182, 1984). In this report, the v-rel sequences important for transformation were defined by constructing recombinant retroviruses in which c-rel sequences replaced the analogous v-rel sequences. These recombinant viruses expressing chimeric proteins were tested for their ability to transform spleen cells in vitro and to induce tumors in young chickens. Activation of the oncogenicity of c-rel in Rev-T required alteration of the amino terminus and the central region of the protein. Deletion of the noncoding sequences 3' to c-rel and of most of the helper virus-related env sequences was necessary for the formation of Rev-T.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3025667      PMCID: PMC367256          DOI: 10.1128/mcb.6.12.4709-4716.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  36 in total

1.  Hematopoietic cell transformation by reticuloendotheliosis virus: characterization of the genetic defect.

Authors:  J D Hoelzer; R B Lewis; C R Wasmuth; H R Bose
Journal:  Virology       Date:  1980-01-30       Impact factor: 3.616

2.  Biological studies with RE virus (strain T) that induces reticuloendotheliosis in turkeys, chickens, and Japanese quail.

Authors:  G H Theilen; R F Zeigel; M J Twiehaus
Journal:  J Natl Cancer Inst       Date:  1966-12       Impact factor: 13.506

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

Review 4.  Form and function of retroviral proviruses.

Authors:  H E Varmus
Journal:  Science       Date:  1982-05-21       Impact factor: 47.728

5.  Hematopoietic cells transformed in vitro by REVT avian reticuloendotheliosis virus express characteristics of very immature lymphoid cells.

Authors:  H Beug; H Müller; S Grieser; G Doederlein; T Graf
Journal:  Virology       Date:  1981-12       Impact factor: 3.616

6.  Formation of infectious progeny virus after insertion of herpes simplex thymidine kinase gene into DNA of an avian retrovirus.

Authors:  K Shimotohno; H M Temin
Journal:  Cell       Date:  1981-10       Impact factor: 41.582

7.  Activation of the transforming potential of a normal cell sequence: a molecular model for oncogenesis.

Authors:  D G Blair; M Oskarsson; T G Wood; W L McClements; P J Fischinger; G G Vande Woude
Journal:  Science       Date:  1981-05-22       Impact factor: 47.728

8.  Genome of reticuloendotheliosis virus: characterization by use of cloned proviral DNA.

Authors:  N R Rice; R R Hiebsch; M A Gonda; H R Bose; R V Gilden
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

9.  Characterization of reticuloendotheliosis virus strain T DNA and isolation of a novel variant of reticuloendotheliosis virus strain T by molecular cloning.

Authors:  I S Chen; T W Mak; J J O'Rear; H M Temin
Journal:  J Virol       Date:  1981-12       Impact factor: 5.103

10.  ras gene Amplification and malignant transformation.

Authors:  S Pulciani; E Santos; L K Long; V Sorrentino; M Barbacid
Journal:  Mol Cell Biol       Date:  1985-10       Impact factor: 4.272

View more
  19 in total

Review 1.  NF-kappaB in pancreatic cancer.

Authors:  Guido M Sclabas; Shuichi Fujioka; Christian Schmidt; Douglas B Evans; Paul J Chiao
Journal:  Int J Gastrointest Cancer       Date:  2003

2.  The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.

Authors:  W H Walker; B Stein; P A Ganchi; J A Hoffman; P A Kaufman; D W Ballard; M Hannink; W C Greene
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

3.  Oncogenic transformation by vrel requires an amino-terminal activation domain.

Authors:  J Kamens; P Richardson; G Mosialos; R Brent; T Gilmore
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

4.  Loss of IkappaB alpha-mediated control over nuclear import and DNA binding enables oncogenic activation of c-Rel.

Authors:  S Sachdev; M Hannink
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

5.  Transactivation of gene expression by nuclear and cytoplasmic rel proteins.

Authors:  M Hannink; H M Temin
Journal:  Mol Cell Biol       Date:  1989-10       Impact factor: 4.272

6.  v-rel oncoproteins in the nucleus and in the cytoplasm transform chicken spleen cells.

Authors:  T D Gilmore; H M Temin
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

7.  Determination of the rate of base-pair substitution and insertion mutations in retrovirus replication.

Authors:  J P Dougherty; H M Temin
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

8.  Mechanism of c-erbB transduction: newly released transducing viruses retain poly(A) tracts of erbB transcripts and encode C-terminally intact erbB proteins.

Authors:  M A Raines; N J Maihle; C Moscovici; L Crittenden; H J Kung
Journal:  J Virol       Date:  1988-07       Impact factor: 5.103

9.  The role of constitutive NF-kappaB activity in PC-3 human prostate cancer cell invasive behavior.

Authors:  P F Lindholm; J Bub; S Kaul; V B Shidham; A Kajdacsy-Balla
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

10.  In vivo footprinting analysis of constitutive and inducible protein-DNA interactions at the long terminal repeat of human immunodeficiency virus type 1.

Authors:  F Demarchi; P D'Agaro; A Falaschi; M Giacca
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.